ReviewNeuroimage. Reports2026
A scoping review of portable ultra-low-field MRI studies in patients with acquired brain injury: Past, present, and future.
Review in Neuroimage. Reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Canine brain imaging with a new low-field portable (0.05 T) MRI scanner: a pilotThe veterinary quarterly · 2026Article
- Advancing the Volumetric Analysis of Ultra-Low-Field Brain MRI Using Image-to-Image Translation.Magnetic resonance in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acquired Brain Injury (ABI) refers to any post-birth damage to the brain, commonly resulting from traumatic events (traumatic brain injury) or non-traumatic events (such as stroke, brain disease, or infection). In Australia, ABI places a substantial economic burden on society. Assessment using high-field (HF) MRI is critical after sustaining an ABI however its usage is impeded by scanner availability and stringent safety requirements. Portable ultra-low-field (ULF MRI) may address these challenges. This review summarises literature on portable ULF MRI use in ABI patients, and outlines its safety and efficacy in detecting structural abnormalities and assessing extent of damage. A systematic search using four databases yielded 20 studies: six studies in stroke, one in traumatic brain injury (TBI), three in brain tumours, three in multiple sclerosis, and eight in other neurological disorders. The findings suggest that portable ULF MRI has been used primarily in critical care and found it was safe for use in the presence of ferromagnetic material and with patients on mechanical aids (e.g. ventilator). Most studies also reported high sensitivity and specificity in detecting various lesions (e.g. ischemic stroke, TBI), particularly those that utilised deep learning to generate a synthetic scan. Strong volumetric correlations between portable ULF MRI and traditional neuroimaging were also reported. Portable ULF MRI usage in ABI patients is encouraging, however lack of diverse ABI samples and quantitative analyses limit its generalisability. Studies in a research context, carried out under controlled conditions, with larger samples (and across multiple centres) are necessary to ascertain portable ULF MRI's validity and reliability vis-à-vis conventional HF MRI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.